Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 3, 1999

View Archived Issues

Antisoma Partners With Abbott For Cancer Product In Phase III

MHC Genome Aids Research Into Cause Of Many Diseases

Sugen Founder Criticizes UK Measures In Containing Costs

DrugAbuse Sciences Raises $22.4M In Private Financing

GenProfile Plans To Exploit Advances In Gene Analysis

Genomics Company Genfit Plans On Public Partnerships

Vanguard Medica Set Back As FDA Asks For More Data

EU Puts Off Decisions On Three Biotech Applications

Teva Offers Novopharm $700M For All Except Biotech Division

Cortecs Reduces R&D Focus As Part Of Change In Strategy

European Investment Bank Plans First Action In Biotech

NicOx Reduces Initial Offering After Doubt From U.S. Investors

Qiagen Among Companies Joining E-Commerce Alliance

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...